Epidemic pertussis in 2012 - The resurgence of a vaccine-preventable disease

New England Journal of Medicine

Volumn 367, Issue 9, 2012, Pages 785-787

  Cherry, James D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTACTIN; PERTUSSIS TOXIN;

ANTIBODY TITER; BACTERIAL GENETICS; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; COUGHING; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EPIDEMIC; FIMBRIA; IMMUNIZATION; INCIDENCE; INFECTION CONTROL; PERTUSSIS; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; VACCINE FAILURE;

EID: 84865513249     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1209051     Document Type: Article

References (5)

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18:326-82.
2. Cherry JD. The present and future control of pertussis. Clin Infect Dis 2010;51:663-7.
3. Pertussis epidemic - Washington, 2012. MMWR Morb Mortal Wkly Rep 2012;61:517-22.
4. Cherry JD. Why do pertussis vaccines fail? Pediatrics 2012;129:968-70.
5. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr 2012 July 20 (Epub ahead of print).